Syneos Health, Inc. provided earnings guidance for the full year 2021. The company continue to expect full year 2021 total revenue of $5.125 billion to $5.325 billion, representing growth of 16.3% to 20.9%, which includes inorganic growth of approximately 550 to 600 basis points and is net of a headwind of approximately 100 basis points, which is related to the dispositions of contingent staffing and medication adherence during 2020.